Correspondence re: G. C. de Gast et al., phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6 : 1267-1272, 2000 - Reply

Authors
de Gast, GC
Citation
Gc. De Gast, Correspondence re: G. C. de Gast et al., phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6 : 1267-1272, 2000 - Reply, CLIN CANC R, 6(10), 2000, pp. 4167-4167
Citations number
1
Categorie Soggetti
Oncology
Journal title
CLINICAL CANCER RESEARCH
ISSN journal
10780432 → ACNP
Volume
6
Issue
10
Year of publication
2000
Pages
4167 - 4167
Database
ISI
SICI code
1078-0432(200010)6:10<4167:CRGCDG>2.0.ZU;2-B